GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Prolight Diagnostics AB (NGM:PRLD) » Definitions » EV-to-FCF

Prolight Diagnostics AB (NGM:PRLD) EV-to-FCF : -1.89 (As of Sep. 25, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Prolight Diagnostics AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Prolight Diagnostics AB's Enterprise Value is kr71.53 Mil. Prolight Diagnostics AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was kr-37.92 Mil. Therefore, Prolight Diagnostics AB's EV-to-FCF for today is -1.89.

The historical rank and industry rank for Prolight Diagnostics AB's EV-to-FCF or its related term are showing as below:

NGM:PRLD' s EV-to-FCF Range Over the Past 10 Years
Min: -9.94   Med: 0   Max: 0
Current: -2.28

NGM:PRLD's EV-to-FCF is ranked worse than
100% of 363 companies
in the Medical Devices & Instruments industry
Industry Median: 27.94 vs NGM:PRLD: -2.28

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-25), Prolight Diagnostics AB's stock price is kr0.174. Prolight Diagnostics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was kr-0.387. Therefore, Prolight Diagnostics AB's PE Ratio for today is At Loss.


Prolight Diagnostics AB EV-to-FCF Historical Data

The historical data trend for Prolight Diagnostics AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prolight Diagnostics AB EV-to-FCF Chart

Prolight Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -8.45 -14.58 -14.94 - -2.28

Prolight Diagnostics AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.27 -5.81 -2.28 -1.47 -1.57

Competitive Comparison of Prolight Diagnostics AB's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Prolight Diagnostics AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prolight Diagnostics AB's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Prolight Diagnostics AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Prolight Diagnostics AB's EV-to-FCF falls into.



Prolight Diagnostics AB EV-to-FCF Calculation

Prolight Diagnostics AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=71.532/-37.92
=-1.89

Prolight Diagnostics AB's current Enterprise Value is kr71.53 Mil.
Prolight Diagnostics AB's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-37.92 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prolight Diagnostics AB  (NGM:PRLD) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Prolight Diagnostics AB's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.174/-0.387
=At Loss

Prolight Diagnostics AB's share price for today is kr0.174.
Prolight Diagnostics AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.387.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Prolight Diagnostics AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Prolight Diagnostics AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Prolight Diagnostics AB Business Description

Traded in Other Exchanges
N/A
Address
Magistratsvagen 10, Lund, SWE, 223 43
Prolight Diagnostics AB is developing with technology partners near-patient test system based on the patented technology, for use in so-called Point of Care Testing (POCT). The company uses technology such as Mico ELISA and Flex membrane and PLD Micro Flex.